Alonso Ricardo, Winchester, MA (US); Steven James DeMarco, Boxford, MA (US); Sylvia Tobe, Winchester, MA (US); Michelle Denise Hoarty, Billerica, MA (US); Robert Paul Hammer, Maynard, MA (US); Douglas A. Treco, Arlington, MA (US); Kathleen Seyb, Wakefield, MA (US); Vaishnavi Rajagopal, Andover, MA (US); Guo-Qing Tang, Acton, MA (US); Douangsone D. Vadysirisack, Boston, MA (US); and Ramin Farzaneh-Far, Brookline, MA (US)
Assigned to Ra Pharmaceuticals, Inc., Cambridge, MA (US)
Filed by Ra Pharmaceuticals, Inc., Cambridge, MA (US)
Filed on Aug. 12, 2021, as Appl. No. 17/400,267.
Application 17/400,267 is a continuation of application No. 16/466,165, granted, now 11,123,399, previously published as PCT/US2017/065005, filed on Dec. 7, 2017.
Claims priority of provisional application 62/555,711, filed on Sep. 8, 2017.
Claims priority of provisional application 62/525,284, filed on Jun. 27, 2017.
Claims priority of provisional application 62/491,702, filed on Apr. 28, 2017.
Claims priority of provisional application 62/430,959, filed on Dec. 7, 2016.
Prior Publication US 2022/0233632 A1, Jul. 28, 2022